A detailed history of Vanguard Group Inc transactions in Angiodynamics Inc stock. As of the latest transaction made, Vanguard Group Inc holds 2,232,855 shares of ANGO stock, worth $12.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,232,855
Previous 2,268,461 1.57%
Holding current value
$12.7 Million
Previous $17.8 Million 26.3%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$5.27 - $8.03 $187,643 - $285,916
-35,606 Reduced 1.57%
2,232,855 $13.1 Million
Q4 2023

Feb 14, 2024

BUY
$6.17 - $8.04 $841,112 - $1.1 Million
136,323 Added 6.39%
2,268,461 $17.8 Million
Q3 2023

Nov 14, 2023

SELL
$7.02 - $10.32 $4.16 Million - $6.11 Million
-591,939 Reduced 21.73%
2,132,138 $15.6 Million
Q2 2023

Aug 14, 2023

SELL
$8.29 - $11.16 $261,914 - $352,589
-31,594 Reduced 1.15%
2,724,077 $28.4 Million
Q1 2023

May 15, 2023

SELL
$9.1 - $15.48 $237,710 - $404,368
-26,122 Reduced 0.94%
2,755,671 $28.5 Million
Q4 2022

Feb 10, 2023

BUY
$12.06 - $21.55 $2.32 Million - $4.15 Million
192,470 Added 7.43%
2,781,793 $38.3 Million
Q3 2022

Nov 14, 2022

BUY
$19.54 - $24.3 $760,066 - $945,221
38,898 Added 1.53%
2,589,323 $53 Million
Q2 2022

Aug 12, 2022

BUY
$17.83 - $24.49 $24,123 - $33,134
1,353 Added 0.05%
2,550,425 $49.4 Million
Q1 2022

May 13, 2022

SELL
$20.46 - $29.16 $248,629 - $354,352
-12,152 Reduced 0.47%
2,549,072 $54.9 Million
Q4 2021

Feb 14, 2022

BUY
$24.35 - $30.97 $684,429 - $870,504
28,108 Added 1.11%
2,561,224 $70.6 Million
Q3 2021

Nov 12, 2021

BUY
$23.36 - $29.2 $179,147 - $223,934
7,669 Added 0.3%
2,533,116 $65.7 Million
Q2 2021

Aug 13, 2021

BUY
$22.39 - $28.07 $56.5 Million - $70.9 Million
2,525,447 New
2,525,447 $68.5 Million

Others Institutions Holding ANGO

About ANGIODYNAMICS INC


  • Ticker ANGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 39,107,800
  • Market Cap $222M
  • Description
  • AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationally. The company provides NanoKnife ablation syst...
More about ANGO
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.